Chronic Lymphocytic Leukemia Market, Forecast to 2025 - Roche, AstraZeneca, Verastem, Novartis, and AbbVie are Dominating
Chronic Lymphocytic Leukemia Market, Forecast to 2025 - Roche, AstraZeneca, Verastem, Novartis, and AbbVie are Dominating. DUBLIN, Feb. 27, 2020 /PRNewswire/ -- The "Chronic Lymphocytic Leukemia Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The parenteral route of administration segment is expected to witness the largest market revenue share in recent years and expected to do so over the forecast period. By Treatment, Chemotherapy accounts for its largest market share due to its access from decades and owing to the wide range of products that are available in the market contributing to the growth of the market. North America is Expected to Dominate the MarketNorth America is expected to dominate the overall chronic lymphocytic leukemia market throughout the forecast period.A steep rise in incidences of various cancers with the rapid growth of elder individuals. For instance, according to the report published by the American Cancer Society in January 2020, the risk of CLL increases with a rise in the age and estimates that about 9 out of 10 people with CLL are over age 50 which directly drives for growth of the CLL market.Also, an increase in the approvals from regulatory bodies along with ongoing research activities by the major companies in the United States are likely to contribute the largest share of revenue in the region propelling the global chronic lymphocytic leukemia market.Competitive LandscapeThe Chronic lymphocytic leukemia market is moderately competitive and consists of several major players.Few of the key players are developing the biosimilars to the existing chemotherapies while others are launching the generic products trending in the market. For instance, in November 2019, AstraZeneca PLC received US Food and Drug Administration (FDA) approval for its Calquence (acalabrutinib) to treat adult patients with CLL which is expected to impel the global Chronic lymphocytic leukemia market growth throughout the forecast period.Furthermore, few key players are entering into partnerships to develop and increase their market position globally.